Jeffrey Sklar

Dr. Jeffrey Sklar is internationally recognized for his pioneering contributions to the field of molecular pathology and his extensive research in the molecular biology of human diseases. As an Emeritus Professor of Pathology and Senior Research Scientist at Yale School of Medicine, Dr. Sklar has dedicated his career to advancing our understanding of gene regulation and its implications in cancer and other diseases. His academic journey began with a B.A. from Haverford College, followed by an M.D. and a Ph.D. from Yale University, where he honed his expertise in molecular diagnostics. Dr. Sklar's research interests are vast and encompass several critical areas in molecular biology. He has made significant strides in understanding the molecular mechanisms underlying cancer, focusing on gene regulation and chromosomal aberrations. His work in RNA trans-splicing has opened new avenues for therapeutic interventions, while his studies on the genetic predisposition to type 2 diabetes have provided valuable insights into the disease's pathogenesis. In addition to his research on cancer and diabetes, Dr. Sklar has contributed to the field of immunogenetics, exploring the genetic factors that influence immune responses. His work has been instrumental in identifying key genetic markers that could lead to more personalized approaches to treatment and prevention. Throughout his career, Dr. Sklar has been committed to translating his research findings into clinical applications, enhancing the diagnostic and therapeutic options available to patients. His expertise in molecular diagnostics has been pivotal in developing new techniques for early disease detection and monitoring. Dr. Sklar's contributions to the scientific community have been recognized through numerous awards and honors. His work continues to inspire and guide new generations of researchers and clinicians in the field of molecular pathology. As an emeritus professor, he remains actively involved in mentoring young scientists and collaborating on innovative research projects that push the boundaries of our understanding of human disease.